Answers are grounded in this paper and cite their sources.
Of 13,349 hospitalized medical patients monitored in a drug surveillance program, 788 (5.9%) received spironolactone during one or more admissions. Adverse reactions were attributed to spironolactone in 164 patients (20.8%). Hyperkalemia was reported in 68 patients (8.6%). Frequency increased with the level of blood urea nitrogen (BUN) and reached 20.3% in patients with BUN values of 50 mg/100 ml or greater. Hyperkalemia was far more common in patients who received potassium chloride concurrently (15.8%) than in those who did not (5.7%). Of patients with BUN values of 50 mg/100 ml or greater who received potassium chloride, 42.1% became hyperkalemic. Other adverse reactions were less common; dehydration (3.4%), hyponatremia (2.4%), gastrointestinal symptoms (2.3%), neurological disturbances (2.0%), and skin rashes (0.5%). The frequency of these events was not related to BUN levels.
No takes yet. Share an insight, caveat, or question.
David J. Greenblatt (1973) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: